Carman Alenson
Comptroller/Controller/Auditor bei PRIME MEDICINE, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Carman Alenson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01.08.2021 | - |
| Finanzdirektor/CFO | 01.08.2021 | 17.01.2024 |
Karriereverlauf von Carman Alenson
Ehemalige bekannte Positionen von Carman Alenson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07.11.2016 | 30.07.2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.04.2015 | 01.10.2016 |
Ausbildung von Carman Alenson
| Boston University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Israel | 2 |
Operativ
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Carman Alenson
- Erfahrung